NKGen Biotech, Inc. Common Stock (NKGN) Institutional Ownership

Based on Q1 2026 13F filings, institutional ownership of NKGen Biotech, Inc. Common Stock stands at 6.3%, held across 1 reporting institutions.

METEORA CAPITAL, LLC is the largest reported institutional holder of NKGN, with approximately 2,755,935 shares worth $0.00B as of Q1 2026.

No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of NKGN.

Our composite Smart Money Score for NKGN is 47 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

0 institutions opened new positions in NKGN during Q1 2026, while 0 fully exited. 1 added to existing positions and 0 trimmed.

NKGN institutional ownership rose by 1.79 percentage points quarter-over-quarter, with a net change of +0 holders.

The top 10 institutions account for 100.0% of all reported 13F value in NKGN, and the top 25 account for 100.0%.

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.